Entities / Company
GeneDx.
company in Stamford, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 49
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
GeneDx faced a legal investigation prompted by fraud allegations involving Rosen Law Firm.Some support2 reports1 development inside
-
GeneDx, Galatea Bio, and Progyny, Inc. were involved in a strategic collaboration to enhance genetic testing, alongside stock analysis provided by Zacks.Speculative1 report
-
GeneDx provides genetic testing services.Speculative1 report
-
A partnership has been formed between GeneDx, Seattle Children’s, and the University of Washington School of Medicine to conduct the SeqFirst study.Speculative1 report
-
AAP guidance recommends genetic testing for GDD/IDs, leading to a GeneDx stock surge and a price target raise by Jefferies Financial Group.Speculative2 reports
-
Golden Cross indicates bullish breakout potential for GeneDx on August 7, 2025.Some support2 reports
-
Guggenheim raised its price target and maintained Buy rating for GeneDx on July 4, 2025.Speculative1 report
-
Katherine Stueland, Director and CEO of GeneDx, sold shares on July 4, 2025.Speculative1 report
-
Analysts predicted potential stock upside for GeneDx on July 17, 2025.Some support1 report
-
GeneDx was classified into the Zacks Medical Services industry as of July 29, 2025.Some support1 report
-
GeneDx, a medical services company, outperformed the S&P 500 this year.Some support1 report
-
The American Academy of Pediatrics recommends using exome and genome testing as first-line diagnostic care.Some support3 reports
-
GeneDx stock gained while the S&P 500 index slumped on July 30, 2025.Some support1 report
-
GeneDx received a raised fair value assessment and a cautious analyst rating for its stock.Some support2 reports
-
GeneDx began using LinkedIn and Instagram for company communication.Some support2 reports
-
Zscaler is described as a global cloud security company, while GeneDx Holdings operates within the U.S. stock market.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around GeneDx this week
News at the entities that move GeneDx most-
LinkedIn Mentioned togetherBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves GeneDx
-
Instagram OperationalLinton, an artist, is performing in residences in Cambridge and Hanoi, while working and living in Berlin, and maintains a professional presence on Instagram.Moves GeneDx
Connections
The 2 strongest of 49, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganJune 2026
16 events- GeneDx faced a legal investigation prompted by fraud allegations involving Rosen Law Firm.
- GeneDx, Galatea Bio, and Progyny, Inc. were involved in a strategic collaboration to enhance genetic testing, alongside stock analysis provided by Zacks.
- GeneDx provides genetic testing services.
- A partnership has been formed between GeneDx, Seattle Children’s, and the University of Washington School of Medicine to conduct the SeqFirst study.
- AAP guidance recommends genetic testing for GDD/IDs, leading to a GeneDx stock surge and a price target raise by Jefferies Financial Group.
- Golden Cross indicates bullish breakout potential for GeneDx on August 7, 2025.
- Guggenheim raised its price target and maintained Buy rating for GeneDx on July 4, 2025.
- Katherine Stueland, Director and CEO of GeneDx, sold shares on July 4, 2025.
- Analysts predicted potential stock upside for GeneDx on July 17, 2025.
- GeneDx was classified into the Zacks Medical Services industry as of July 29, 2025.
- GeneDx, a medical services company, outperformed the S&P 500 this year.
- The American Academy of Pediatrics recommends using exome and genome testing as first-line diagnostic care.
- GeneDx stock gained while the S&P 500 index slumped on July 30, 2025.
- GeneDx received a raised fair value assessment and a cautious analyst rating for its stock.
- GeneDx began using LinkedIn and Instagram for company communication.
- Zscaler is described as a global cloud security company, while GeneDx Holdings operates within the U.S. stock market.